These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 9577389

  • 21. Assessment of mental deterioration with the Cognitive Abilities Screening Instrument (CASI) and glucose hypometabolism in Alzheimer's disease: the Osaki-Tajiri Project.
    Yamaguchi S, Meguro K, Ishii H, Meguro M, Akanuma K.
    J Clin Neurosci; 2009 Nov; 16(11):1430-4. PubMed ID: 19632119
    [Abstract] [Full Text] [Related]

  • 22. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, Kuhl DE, Schwaiger M.
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [Abstract] [Full Text] [Related]

  • 23. Brain structural, functional, and cognitive correlates of recent versus remote autobiographical memories in amnestic Mild Cognitive Impairment.
    Tomadesso C, Perrotin A, Mutlu J, Mézenge F, Landeau B, Egret S, de la Sayette V, Jonin PY, Eustache F, Desgranges B, Chételat G.
    Neuroimage Clin; 2015 Apr; 8():473-82. PubMed ID: 26106572
    [Abstract] [Full Text] [Related]

  • 24. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
    Küntzelmann A, Guenther T, Haberkorn U, Essig M, Giesel F, Henze R, Schroeter ML, Schröder J, Schönknecht P.
    Neurosci Lett; 2013 Feb 08; 534():12-7. PubMed ID: 23182881
    [Abstract] [Full Text] [Related]

  • 25. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.
    Am J Psychiatry; 2002 May 08; 159(5):738-45. PubMed ID: 11986126
    [Abstract] [Full Text] [Related]

  • 26. Positron emission tomography metabolic correlates of apathy in Alzheimer disease.
    Marshall GA, Monserratt L, Harwood D, Mandelkern M, Cummings JL, Sultzer DL.
    Arch Neurol; 2007 Jul 08; 64(7):1015-20. PubMed ID: 17620493
    [Abstract] [Full Text] [Related]

  • 27. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O, Meyer PM, Gräf S, Hesse S, Wilke S, Becker GA, Rullmann M, Patt M, Luthardt J, Wagenknecht G, Hoepping A, Smits R, Franke A, Sattler B, Tiepolt S, Fischer S, Deuther-Conrad W, Hegerl U, Barthel H, Schönknecht P, Brust P.
    Brain; 2018 Jun 01; 141(6):1840-1854. PubMed ID: 29672680
    [Abstract] [Full Text] [Related]

  • 28. [Relationship between episodic memory and resting-state brain functional connectivity network in patients with Alzheimer's disease and mild cognition impairment].
    Wu QJ, Guo ZJ, Liu SE, Yu HQ, Chen J, Yang HM.
    Zhonghua Yi Xue Za Zhi; 2013 Jun 18; 93(23):1795-800. PubMed ID: 24124712
    [Abstract] [Full Text] [Related]

  • 29. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P, Furey ML, Graff-Radford N, Freo U, Alexander GE, Grady CL, Dani A, Mentis MJ, Schapiro MB.
    Am J Psychiatry; 1996 Oct 18; 153(10):1261-8. PubMed ID: 8831432
    [Abstract] [Full Text] [Related]

  • 30. Hemisphere-specific episodic memory networks in the human brain: a correlation study between intracarotid amobarbital test and [(18)F]FDG-PET.
    Akanuma N, Reed LJ, Marsden PK, Jarosz J, Adachi N, Hallett WA, Alarcón G, Morris RG, Koutroumanidis M.
    J Cogn Neurosci; 2009 Mar 18; 21(3):605-22. PubMed ID: 18564051
    [Abstract] [Full Text] [Related]

  • 31. Controlled memory processes in questionable Alzheimer's disease: a view from neuroimaging research.
    Bastin C, Kerrouche N, Lekeu F, Adam S, Guillaume B, Lemaire C, Aerts J, d'Ydewalle G, Collette F, Salmon E.
    J Alzheimers Dis; 2010 Mar 18; 20(2):547-60. PubMed ID: 20164554
    [Abstract] [Full Text] [Related]

  • 32. Lexical factors and cerebral regions influencing verbal fluency performance in MCI.
    Clark DG, Wadley VG, Kapur P, DeRamus TP, Singletary B, Nicholas AP, Blanton PD, Lokken K, Deshpande H, Marson D, Deutsch G.
    Neuropsychologia; 2014 Feb 18; 54():98-111. PubMed ID: 24384308
    [Abstract] [Full Text] [Related]

  • 33. Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment.
    Joubert S, Gour N, Guedj E, Didic M, Guériot C, Koric L, Ranjeva JP, Felician O, Guye M, Ceccaldi M.
    Cortex; 2016 Jan 18; 74():217-32. PubMed ID: 26694580
    [Abstract] [Full Text] [Related]

  • 34. Famous faces and voices: Differential profiles in early right and left semantic dementia and in Alzheimer's disease.
    Luzzi S, Baldinelli S, Ranaldi V, Fabi K, Cafazzo V, Fringuelli F, Silvestrini M, Provinciali L, Reverberi C, Gainotti G.
    Neuropsychologia; 2017 Jan 08; 94():118-128. PubMed ID: 27916672
    [Abstract] [Full Text] [Related]

  • 35. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A.
    Eur J Nucl Med Mol Imaging; 2003 Aug 08; 30(8):1104-13. PubMed ID: 12764551
    [Abstract] [Full Text] [Related]

  • 36. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
    Okamura N, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Harada R, Yates P, Pejoska S, Kudo Y, Masters CL, Yanai K, Rowe CC, Villemagne VL.
    Brain; 2014 Jun 08; 137(Pt 6):1762-71. PubMed ID: 24681664
    [Abstract] [Full Text] [Related]

  • 37. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y, Cho SS, Park JM, Kang SJ, Lee JS, Kang E, Na DL, Kim SE.
    J Nucl Med; 2005 Feb 08; 46(2):233-9. PubMed ID: 15695781
    [Abstract] [Full Text] [Related]

  • 38. Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease.
    Fouquet M, Desgranges B, Landeau B, Duchesnay E, Mézenge F, de la Sayette V, Viader F, Baron JC, Eustache F, Chételat G.
    Brain; 2009 Aug 08; 132(Pt 8):2058-67. PubMed ID: 19477964
    [Abstract] [Full Text] [Related]

  • 39. On the multivariate nature of brain metabolic impairment in Alzheimer's disease.
    Salmon E, Kerrouche N, Perani D, Lekeu F, Holthoff V, Beuthien-Baumann B, Sorbi S, Lemaire C, Collette F, Herholz K.
    Neurobiol Aging; 2009 Feb 08; 30(2):186-97. PubMed ID: 17651869
    [Abstract] [Full Text] [Related]

  • 40. Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity.
    Marchitelli R, Aiello M, Cachia A, Quarantelli M, Cavaliere C, Postiglione A, Tedeschi G, Montella P, Milan G, Salvatore M, Salvatore E, Baron JC, Pappatà S.
    Neuroimage; 2018 Aug 01; 176():246-258. PubMed ID: 29709628
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.